PBMCs from MS patients stimulated to pHERV-W env 486-504 showed that CD8+ T–cells expressed cytokines at frequencies greater than 0.5% and 0.4% compared to DMSO and syncytin-1 env 486-500, respectively (Figure 3). The gene discussed is CD8A; the disease is myeloid sarcoma.